{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ImmunoPrecise Antibodies Ltd."},"Symbol":{"label":"Symbol","value":"IPA"},"Address":{"label":"Address","value":"3204 - 4464 MARKHAM STREET, VICTORIA, British Columbia, V8Z 7X8, Canada"},"Phone":{"label":"Phone","value":"+1 (800) 620-4187"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the \"IPA Family\")."},"CompanyUrl":{"label":"Company Url","value":"https://www.immunoprecise.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ilse Roodink","title":"Chief Scientific Officer"},{"name":"Jennifer L. Bath","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}